Ellen Liu, MD
Interventional Cardiology · Westerville, OHNPI 1316309016
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,214 of the $3,335 with a category attached, or 66.4%. 9 manufacturers reported payments, led by Boston Scientific at 47.6% of the total. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.
Across 33 payments — averaging $101.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abiomed$1K
- Abbott$147
- ZOLL Circulation Inc$142
- AstraZeneca$129
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$77
- plus $160 from 3 others
What the payments were for
- Travel & lodging$1,12134%
- Food & beverage$2,21466%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $1,588 |
| Abiomed | 11 | $1,091 |
| Abbott | 1 | $147 |
| ZOLL Circulation Inc | 1 | $142 |
| AstraZeneca | 1 | $129 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $77 |
| Chiesi USA, Inc. | 1 | $72 |
| Penumbra, Inc. | 1 | $48 |
| Cardiovascular Systems Inc. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTICROSS$150
- MitraClip$147
- AVVIGO Guidance System$147
- TherOx DS2 Console$142
- Catheter$142
- Downstream Cartridge$142
- GENERAL VASCULAR ACCESS$133
- BRILINTA$129
- Impella$111
How this compares
$3,335 in reported general payments places this provider in the 40th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $54 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Westerville
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
- Atish MathurMansfield$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.